Association Between Vitamin D and Carboxy-Terminal Cross-Linked Telopeptide of Type I Collagen in Children During Growth Hormone Replacement Therapy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/5584_2017_109PMID 28936809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial

  2017cited by this paper
• Bone turnover markers: Emerging tool in the management of osteoporosis

  2016cited by this paper
• Novel biological markers of bone: from bone metabolism to bone physiology.

  2016cited by this paper
• Biochemical markers of bone turnover in children with clinical bone fragility

  2016cited by this paper
• Vitamin D deficiency, bone turnover markers and causative factors among adolescents: a cross-sectional study

  2016cited by this paper
• Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice

  2015cited by this paper
• Short‐term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion

  2015cited by this paper
• Bone turnover markers in the obese children - relation to gender, body composition and leptin level.

  2015cited by this paper
• Associations between serum 25-hydroxyvitamin D and bone turnover markers in a population based sample of German children

  2015cited by this paper
• Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products

  2014cited by this paper
• New developments in biological markers of bone metabolism in osteoporosis.

  2014cited by this paper
• Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis

  2014cited by this paper
• Serum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover

  2014cited by this paper
• Bone Remodelling Markers in Rheumatoid Arthritis

  2014cited by this paper
• The clinical utility of bone marker measurements in osteoporosis

  2013cited by this paper
• Serum collagen markers and heart failure.

  2012cited by this paper
• Consensus on the utility of bone markers in the malignant bone disease setting.

  2011cited by this paper
• Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly.

  2010cited by this paper
• Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells.

  2007cited by this paper
• Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodedeling.

  2003cited by this paper
• Pubertal Changes in Biochemical Markers of Growth

  2003cited by this paper
• Responses of Bone Turnover Markers and Bone Mineral Density to Growth Hormone Therapy in Ghildren with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies

  2002cited by this paper
• Bone metabolism markers and bone mass in healthy pubertal boys and girls

  2002cited by this paper
• Dynamics of bone turnover in children with GH deficiency treated with GH until final height.

  2000cited by this paper
• Biochemical Measurements of Bone Turnover in Children and Adolescents

  2000cited by this paper
• Radiographic Atlas of Skeletal Development of the Hand and Wrist

  1999cited by this paper
• Collagen formation and degradation increase during growth hormone therapy in children.

  1997cited by this paper
• Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.

  1995cited by this paper

• Vitamin D status and response to growth hormone treatment in prepubertal children with growth hormone deficiency

  2020cites this paper
• Vitamin D and growth hormone in children: a review of the current scientific knowledge

  2019cites this paper
• The relationship between alkaline phosphatase and bone alkaline phosphatase activity and the growth hormone/insulin-like growth factor-1 axis and vitamin D status in children with growth hormone deficiency.

  2018cites this paper
• Osteoprotegerin, Receptor Activator of Nuclear Factor Kappa B Ligand, and Growth Hormone/Insulin-Like Growth Factor-1 Axis in Children with Growth Hormone Deficiency.

  2018cites this paper